Dr. Whitebrook is a Director at Deloitte Consulting LLP and leader of the Drug Safety & PV practice. He has been consulting in the DS&PV space since 2001. He was responsible for Corporate Safety Systems at Pfizer. He worked for Glaxo Wellcome, in NC, leading a CDMS project. Prior to that he worked for Glaxo in the UK and was responsible for GI portfolio data management activities. Dr. Whitebrook earned his B.Sc. from Liverpool University in 1981 and his Ph.D. from Bristol University in 1986.